Effect of Chemical Attack Inhibitor Dosage on the Performance of Self-Compacting Concrete and Its Micro-Mechanisms
Materials · 23.06.2026 · 19 (13) · 2697
DOI: 10.3390/ma19132697 ↗Kurz gefasst
Fachartikel in der Zeitschrift Materials, online erschienen am 23.06.2026. Verfasst von Yuedong Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Iron and Steel Industry Environmental Protection, Central Research Institute of Building and Construction Co., Ltd., Beijing …. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Key R&D Program of China (2023YFB3711400) and Beijing Nova Program, National Key R&D Program of China, Beijing Nova Program.
Abstract (Originalsprache)
Self-compacting concrete (SCC) is widely adopted in complex structural engineering due to its excellent flowability and filling capacity. However, in harsh corrosive environments, its complex internal pore structure can easily serve as a preferential pathway for the transport of aggressive media, leading to durability deterioration. This study systematically investigates the effects of chemical attack inhibitor (CAI) on the workability, mechanical properties, sulfate attack resistance, and chloride ion penetration resistance of SCC. The micro-mechanisms governing pore structure evolution are elucidated using low-field nuclear magnetic resonance (LF-NMR) and X-ray computed tomography (X-CT). At a CAI dosage of 2%, the fresh SCC exhibits a slump of 260 mm and slump flow of 720 mm, indicating excellent filling and gap-passing abilities. Meanwhile, the compressive strengths at 3 d, 7 d, and 28 d remain at a high level. After 120 sulfate wet-dry cycles, the strength loss rate is only 8.4%, with an erosion resistance coefficient exceeding 90%. In addition, the resistance to chloride ion penetration is significantly improved, with an electric flux of only 1331 C, which is considerably lower than that of the control group (1637 C). At the optimal dosage of CAI, the concrete exhibits a dense and uniform internal structure devoid of macroscopic defects or cracks, with minimized porosity, thus synergistically enhancing the resistance to sulfate attack and chloride attack. On the contrary, further increasing the CAI dosage markedly intensifies the inhibitory effect of organic components on cement hydration, leading to increased early-age defects and enhanced pore connectivity. Thus, an appropriate amount of CAI can effectively improve the overall performance of SCC, providing a solid experimental basis and theoretical support for its engineering application in harsh corrosive environments.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Iron and Steel Industry Environmental Protection, Central Research Institute of Building and Construction Co., Ltd., Beijing 102629, China.
- Tianjin Key Laboratory of Building Green Functional Materials, School of Materials and Engineering, Tianjin Chengjian University, Tianjin 300384, China.
Förderung
- the National Key R&D Program of China (2023YFB3711400) and Beijing Nova Program
- National Key R&D Program of China
- Beijing Nova Program
Zitieren
APA
Wu, Y., Wang, J., Zhang, F., Li, G., Lv, W., Xu, R., Zhang, L., & Wang, T. (2026). Effect of Chemical Attack Inhibitor Dosage on the Performance of Self-Compacting Concrete and Its Micro-Mechanisms. Materials, 19(13), 2697. https://doi.org/10.3390/ma19132697
Vancouver
Wu Y, Wang J, Zhang F, Li G, Lv W, Xu R, et al. Effect of Chemical Attack Inhibitor Dosage on the Performance of Self-Compacting Concrete and Its Micro-Mechanisms. Materials. 2026;19(13):2697. doi:10.3390/ma19132697
BibTeX
@article{Wu2026,
author = {Wu, Yuedong and Wang, Jiaxiang and Zhang, Fangbin and Li, Gen and Lv, Wen and Xu, Rui and Zhang, Lei and Wang, Tianlei},
title = {Effect of Chemical Attack Inhibitor Dosage on the Performance of Self-Compacting Concrete and Its Micro-Mechanisms},
journal = {Materials},
year = {2026},
volume = {19},
number = {13},
pages = {2697},
doi = {10.3390/ma19132697}
}
EUVIMED